Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
暂无分享,去创建一个
E. Anaissie | G. Lyon | K. Wannemuehler | B. Alexander | T. Perl | V. Morrison | J. Ito | D. Kontoyiannis | Benjamin J Park | T. Walsh | D. Andes | T. Chiller | K. Marr | R. Oster | L. Herwaldt | T. Patterson | P. Pappas | C. Kauffman | R. Walker | A. Freifeld | L. Brumble | S. Hadley | Thomas J. Walsh | M. Schuster | P. Pappas | T. Walsh
[1] David Burgner,et al. HLA and Infectious Diseases , 2009, Clinical Microbiology Reviews.
[2] A. Bingaman,et al. Campath Induction for Kidney Transplantation: Report of 297 Cases , 2008, Transplantation.
[3] Patricia Muñoz,et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] H. Antretter,et al. Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients , 2008, Transplant international : official journal of the European Society for Organ Transplantation.
[5] J. Fechner,et al. CD4+CD25+FOXP3+ Regulatory T Cells Increase De Novo in Kidney Transplant Patients After Immunodepletion with Campath‐1H , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[6] R. Betts,et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] N. Milman,et al. Aspergillus infection in lung transplant patients: incidence and prognosis , 2007, European Journal of Clinical Microbiology & Infectious Diseases.
[8] D. Diso,et al. Incidence of fungal infections in a solid organ recipients dedicated intensive care unit. , 2007, Transplantation proceedings.
[9] R. Betts,et al. Anidulafungin versus fluconazole for invasive candidiasis. , 2007, The New England journal of medicine.
[10] S. Husain,et al. Fungal infections in solid organ transplantation. , 2007, Medical mycology.
[11] D. Pakstis,et al. Voriconazole Prophylaxis in Lung Transplant Recipients , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] Rima A. Mohammad,et al. Inhaled Amphotericin B for Prophylaxis Against Invasive Aspergillus Infections , 2006, The Annals of pharmacotherapy.
[13] C. Agustí,et al. Invasive pulmonary aspergillosis in solid organ and bone marrow transplant recipients. , 2005, Transplantation proceedings.
[14] C. Viscoli,et al. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial , 2005, The Lancet.
[15] R. Gilroy,et al. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center , 2005, Transplant infectious disease : an official journal of the Transplantation Society.
[16] P. Muñoz,et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] R. Kandaswamy,et al. Calcineurin Inhibitor- and Steroid-Free Immunosuppression in Pancreas-Kidney and Solitary Pancreas Transplantation , 2005, Transplantation.
[18] A. Webster,et al. Antifungal agents for preventing fungal infections in solid organ transplant recipients. , 2004, The Cochrane database of systematic reviews.
[19] Lee H. Harrison,et al. Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program , 2004, Journal of Clinical Microbiology.
[20] Patty W. Wright,et al. Donor-related coccidioidomycosis in organ transplant recipients. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] N. J. Mueller,et al. Asymptomatic pulmonary cryptococcosis in solid organ transplantation: report of four cases and review of the literature , 2003, Transplant infectious disease : an official journal of the Transplantation Society.
[22] J. Fung,et al. Longitudinal study of cryptococcosis in adult solid-organ transplant recipients , 2003, Transplant international : official journal of the European Society for Organ Transplantation.
[23] Nina Singh,et al. Fungal infections in the recipients of solid organ transplantation. , 2003, Infectious disease clinics of North America.
[24] N. Smedira,et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants , 2002, Transplant infectious disease : an official journal of the Transplantation Society.
[25] P. Martín-Dávila,et al. Risk factors for invasive aspergillosis in liver transplant recipients , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] J. Fung,et al. Cryptococcosis in Organ Transplant Recipients: An Overview , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[27] R. Patel. Infections in recipients of kidney transplants. , 2001, Infectious disease clinics of North America.
[28] Nina Singh,et al. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. , 2001, Emerging infectious diseases.
[29] N. Singh. Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[30] P. Grossi,et al. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. , 2000, Transplantation.
[31] Scott B. Johnson,et al. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients , 2000, Transplant infectious disease : an official journal of the Transplantation Society.
[32] D. Dunn,et al. Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. , 1996, Journal of the American College of Surgeons.
[33] S. Todo,et al. Infectious complications after small bowel transplantation in adults: an update. , 1996, Transplantation proceedings.
[34] A. Karchmer,et al. Fungal infections in solid organ transplant recipients. , 1995, Infectious disease clinics of North America.
[35] M. Samore,et al. Risk factors for invasive fungal infections complicating orthotopic liver transplantation. , 1994, The Journal of infectious diseases.